AliveDx Suisse S.A. and PZ Cormay S.A. have signed a distribution agreement, which will enable PZ Cormay to distribute the MosaiQ® solution in Poland. The distribution agreement takes effect immediately.
AliveDx is dedicated to expanding its reach and presence across various regions and to creating clinical and economical value for clinicians, helping them to shorten the time to diagnosis. This significant partnership with a key player in Poland highlights the company’s dedication to advancing the healthcare sector and improving patient care.
The MosaiQ platform simplifies workflows and creates efficiencies thanks to its multiplexing microarray assay technology. This streamlined and efficient approach offers faster and more cost-effective solutions to healthcare providers and patients alike.
“This is yet another excellent chance to showcase AliveDx’s commitment to revolutionizing patient care worldwide and supporting the healthcare system with innovative and fast diagnostic solutions. We look forward to partnering with PZ Cormay,” said Manuel O. Méndez, CEO of AliveDx.
PZ Cormay offers world-class medical and diagnostic equipment to doctors and laboratory specialists. The group is supported by an experienced, international research and development team, and its products are exported to over 150 countries around the world.
“Our comprehensive offer of IVD solutions combines the high quality of our products and the proven technology of the distributed brands. We look forward to working with AliveDx and introducing the outstanding MosaiQ solution to the Polish market,” said Flavio Finotello, CEO of PZ Cormay.
To learn more, please visit the Cormay website.
